Clin2
NCT06144125Likely a fitRecruiting

Blood management trial for heart surgery patients

Cardiac Valve Disease

Treatments studied

Part of Blood & lymphatic, Genetic & congenital, Heart & circulation clinical trials.

This trial compares two treatments (prothrombin complex concentrate and fresh frozen plasma) for managing bleeding during heart surgery. It aims to find which approach works better and is safer for patients.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
20 years to 75 years
Study type
Interventional

Who can take part

  • You are scheduled to have heart surgery
  • You do not have a low platelet count (thrombocytopenia)
  • You are not taking blood thinners (oral anticoagulants)
  • You are not taking antiplatelet medications (like aspirin or clopidogrel)

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06332547Not yet recruiting
Blood transfusion study for heart valve surgery

This trial studies blood transfusion practices during planned heart valve surgery. It aims to find the best way to use blood transfusions to improve recovery after surgery.

Guangzhou, Guangdong
NCT07094087Recruiting· Phase 3
Blood clotting medicine for heart surgery bleeding

This trial tests a medicine called 4F-PCC to stop bleeding during complex heart surgery that uses a heart-lung machine. It could help people who have bleeding problems after the surgery.

Los Angeles, California
NCT06109155Recruiting· Phase 4
Comparing medications to reduce bleeding in heart surgery

This trial tests two medicines—ACT (a blood thinner) and tranexamic acid (a medicine to reduce bleeding)—to see which is better at controlling bleeding during heart surgery. It is for adults having planned heart surgery with a heart-lung machine.

Taichung
NCT06425614Recruiting
Blood Cell Recycling During Heart Surgery Trial

This trial tests whether giving back a patient's own platelets and red blood cells during heart surgery can reduce bleeding and the need for donor blood transfusions. It is for people having certain types of high-risk heart surgery with a heart-lung machine.

Bordeaux, France
NCT07032792Recruiting· Phase 2
FEIBA versus plasma for bleeding after heart surgery

This trial compares two treatments for bleeding after heart surgery: a medicine called FEIBA (which helps blood clot) and fresh frozen plasma (a blood product). The goal is to see which works better as a first treatment for bleeding during recovery.

Manhasset, New York
NCT07366606Not yet recruiting
Bleeding management in open heart surgery

This trial tests a method to control bleeding during open heart surgery. It may help you if you are planning to have this surgery.

Hear when a new Cardiac Valve Disease trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.